Close Menu

NEW YORK – The Personalized Medicine Coalition said this week that the number of personalized medicines on the market in the US has more than doubled over the past four years.

According to the sixth edition of the organization's Personalized Medicine Report, the number of individualized medicines on the US market grew from 132 in 2016 to 286 in 2020, a 116 percent spike and the largest four-year increase since it began tracking this figure in 2008. In contrast, between 2012 and 2016 precision therapies grew only about 62 percent.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.